Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006419
Filing Date
2022-02-15
Accepted
2022-02-15 16:48:05
Documents
1
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6947
  Complete submission text file 0000899243-22-006419.txt   8474
Mailing Address WOLDPROMENADE 18C GAUTING 2M 82131
Business Address
Baeuerle Patrick (Reporting) CIK: 0001362054 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 22639848

Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)